bavencio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Allow: / Disallow: /content/dam/web/health-care/biopharma/web/Bavencio/us/practice-share-digital-papers/*.pdf Disallow: /hcp/rcc/clinical-perspectives-*-region Disallow: /content/dam/web/health-care/biopharma/web/Bavencio/us/uc-documents/1L-UC_Therapy-Management-Guide-Digital/*.pdf Disallow: /hcp/uc/UC_Therapy_Management_Guide Disallow: /content/dam/web/health-care/biopharma/web/Bavencio/us/US-AVE-0320-0051d-1/*.pdf Disallow: /hcp/uc/UC_Clinical_Brochure Disallow: /content/dam/web/health-care/biopharma/web/Bavencio/us/uc-documents/MCC_UC_Therapy_Management_Guide/*.pdf Disallow: /hcp/uc/MCC_UC_Therapy_Management_Guide Disallow: /content/dam/web/health-care/biopharma/web/Bavencio/us/uc-documents/1LM_UC_Clinical_Brochure/*.pdf Disallow: /hcp/uc/1LM_UC_Clinical_Brochure Disallow: /content/dam/web/health-care/biopharma/web/Bavencio/us/uc-documents/Nurse_Handbook/*.pdf Disallow: /hcp/uc/Nurse_Handbook Disallow: | ||
Meta Tags
| Title | BAVENCIO® (avelumab) | For Healthcare |
| Description | The FIRST and ONLY immunotherapy approved in the first-line maintenance setting for patients with See risks and benefits of BAVENCIO® (avelumab). Get HCP info & learn how BAVENCIO may treat metastatic Merkel cell carcinoma & previously treated advanced urothelial |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 51.91.60.4 |
| Location | United Kingdom |
Related Websites
| Site | Rank |
More to Explore
bavencio.com Valuation
|
US$12,411,267
Last updated: 2023-05-03 14:55:23
bavencio.com has Semrush global rank of 852,798. bavencio.com has an estimated worth of US$ 12,411,267, based on its estimated Ads revenue. bavencio.com receives approximately 1,432,070 unique visitors each day. Its web server is located in United Kingdom, with IP address 51.91.60.4. According to SiteAdvisor, bavencio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$12,411,267 |
| Daily Ads Revenue | US$11,457 |
| Monthly Ads Revenue | US$343,697 |
| Yearly Ads Revenue | US$4,124,360 |
| Daily Unique Visitors | 95,472 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| bavencio.com. | A | 600 | IP: 51.91.60.4 |
| bavencio.com. | AAAA | 600 | IPV6: 2001:41d0:301:100:51:91:60:4 |
| bavencio.com. | NS | 300 | NS Record: ns2.brandshelter.de. |
| bavencio.com. | NS | 300 | NS Record: ns4.brandshelter.net. |
| bavencio.com. | NS | 300 | NS Record: ns1.brandshelter.com. |
| bavencio.com. | NS | 300 | NS Record: ns5.brandshelter.us. |
| bavencio.com. | NS | 300 | NS Record: ns3.brandshelter.info. |
| bavencio.com. | TXT | 300 | TXT Record: 9DAA-6F09-B37E-475C-29C3-85C2-F292-E971 |
| bavencio.com. | TXT | 300 | TXT Record: cch55l2831xtz6f4hq7ykc09lsfb5501 |
| bavencio.com. | TXT | 300 | TXT Record: google-site-verification=Rr370IqSYQpQvzybKGDcIFdcECRLYT2IRLTDxGN2Bpg |
HtmlToTextCheckTime:2023-05-03 14:55:23
| Indications Important Safety Information Prescribing Information Medication Guide Patient Website Nurse Portal FOR CERTAIN PATIENTS WITH locally advanced or metastatic UC FOR CERTAIN PATIENTS WITH metastatic MCC Request a Rep Select a tumor type FOR CERTAIN PATIENTS WITH locally advanced or metastatic UC FOR CERTAIN PATIENTS WITH metastatic MCC For combination treatment of another tumor type The FIRST and ONLY immunotherapy approved in the first-line maintenance setting for patients with locally advanced or metastatic urothelial carcinoma BAVENCIO ® (avelumab) is indicated for the maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma (UC) that has not progressed with first-line platinum-containing chemotherapy. EXPLORE THE OVERALL SURVIVAL DATA National Comprehensive Cancer Network ® (NCCN ® ) Recommendation Avelumab (BAVENCIO) maintenance is the only NCCN CATEGORY 1 and PREFERRED immunotherapy option for both cisplatin-eligible and -ineligible |
HTTP Headers
HTTP/1.1 301 Moved Permanently Cache-Control: public, must-revalidate, proxy-revalidate, max-age=3600 Location: http://www.bavencio.com Content-type: text/html; charset=UTF-8 Date: Mon, 25 Oct 2021 20:57:27 GMT X-IPLB-Instance: 31598 HTTP/1.1 301 Moved Permanently Server: AkamaiGHost Content-Length: 0 Location: https://www.bavencio.com/ Date: Mon, 25 Oct 2021 20:57:27 GMT Connection: keep-alive HTTP/2 503 server: AkamaiGHost mime-version: 1.0 content-type: text/html content-length: 176 expires: Mon, 25 Oct 2021 20:57:27 GMT date: Mon, 25 Oct 2021 20:57:27 GMT |
bavencio.com Whois Information
Domain Name: BAVENCIO.COM Registry Domain ID: 1692264390_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.rrpproxy.net Registrar URL: http://www.key-systems.net Updated Date: 2020-11-13T15:00:50Z Creation Date: 2011-12-15T14:28:52Z Registry Expiry Date: 2021-12-15T14:28:52Z Registrar: Key-Systems GmbH Registrar IANA ID: 269 Registrar Abuse Contact Email: abuse@key-systems.net Registrar Abuse Contact Phone: +49.68949396850 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.BRANDSHELTER.COM Name Server: NS2.BRANDSHELTER.DE Name Server: NS3.BRANDSHELTER.INFO Name Server: NS4.BRANDSHELTER.NET Name Server: NS5.BRANDSHELTER.US DNSSEC: unsigned >>> Last update of whois database: 2021-09-13T23:03:50Z <<< |